Book a free demo
H-1B Data › Employers › Enveda Therapeutics, Inc.
Check another employer
H-1B Sponsor Profile

Enveda Therapeutics, Inc. — H-1B Visa Sponsorship Data

12 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2022–FY2026.

Boulder, COActive FY2022–FY2026Transfer-FriendlyFull-Time Roles
● Data current through FY2026 · sourced from U.S. DOL OFLC, updated quarterly
Sponsors H-1B?
Yes
12 certified LCAs
FY2026 filings
4
most recent disclosure year
Median H-1B salary
$162,550
typical $113,750–$188,750
Worksite states
8
8 cities
Transfer share
36%
change-of-employer filings

2 items a DOL auditor would ask Enveda Therapeutics, Inc. about

Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Enveda Therapeutics, Inc.'s own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.

0 need attention2 to watch2 clear
Watch
2 certified LCAs (2 positions) end within 180 days

Next end date: 2026-11-05. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.

Auditor asksWhich workers are on each expiring LCA, and is a superseding LCA already certified?
In your PAFSuperseding LCA, updated PAF entry and new posting notice for every position that continues.
Watch
8 worksites across 8 states

Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.

Auditor asksWhere is the posting record for each worksite, and were short-term placements tracked against the 30/60-day limits?
In your PAFPosting notices (or electronic-notice records) per worksite; new-worksite LCAs; placement log.
Clear
0% of certified LCAs are at Wage Level I

Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.

Auditor asksHow was Level I justified for each role — required education, experience and the actual duties performed?
In your PAFPrevailing-wage determination and wage-level worksheet for every Level I LCA.
Clear
0% of LCAs offer a wage within 2% of the prevailing wage

Median offered wage is 14% above the DOL prevailing wage across 8 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.

Auditor asksShow the actual wage paid (payroll) matches or exceeds the LCA wage for every worker, including benched time.
In your PAFActual-wage memorandum and pay records per LCA; wage-level rationale where the offered wage equals the PW.
Are you Enveda Therapeutics, Inc.? Get the private PAF / LCA gap check.
We compare these public filings against what must be in your Public Access Files and send you the gap list — free, within one business day. No platform migration, no commitment.
Get my private gap check →

Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.

For job seekers

Considering a job at Enveda Therapeutics, Inc.?

Does Enveda Therapeutics, Inc. sponsor H-1B visas?

Yes — Enveda Therapeutics, Inc. sponsors H-1B workers, with 12 certified LCAs on file (FY2022–FY2026), including 4 in FY2026. The median certified salary is $162,550 (P25 $113,750, P75 $188,750). With a 36% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.

What to Know Before Applying to Enveda Therapeutics, Inc.

Salary range
Median $162,550, typical band $113,750–$188,750.
Transfers
36% of filings are transfers — this employer has an established H-1B transfer track record.
Typical locations
Boulder, CO, Lebanon, OH, San Francisco, CA, Indianapolis, IN.
Position type
100% of filings are full-time roles.
Common roles
Associate Vice President, Biomarker Operations Manager, Data Scientist.
Benchmark this employer in the H-1B database →
Looking for your next role?
See open positions on ElevateRecruit, the ElevateStaffing job board.
Browse open jobs →

Frequently asked questions

Yes. Enveda Therapeutics, Inc. has 12 certified Labor Condition Applications (LCAs) on file with the U.S. Department of Labor (FY2022–FY2026).

The median sponsored salary is $162,550, with a typical P25–P75 band of $113,750–$188,750 across certified LCAs.

Yes — 36% of its LCA filings are change-of-employer (transfer) cases, indicating an active transfer pipeline.

Enveda Therapeutics, Inc. filed 4 certified LCAs in FY2026, the most recent fiscal year of U.S. DOL disclosure data.

Top worksites include Boulder, CO, Lebanon, OH, San Francisco, CA, Indianapolis, IN.
Sponsorship data

Enveda Therapeutics, Inc. H-1B data at a glance

Executive Summary

Enveda Therapeutics, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2022–FY2026).

  • Median certified salary is $162,550, typically $113,750–$188,750 (P25–P75).
  • 100% of certified filings are at or above the DOL prevailing wage.
  • Change-of-employer (transfer) share is 36% — workers actively transfer to this employer.
  • Worksite footprint spans 8 states and 8 cities.
  • Most-sponsored roles: Associate Vice President, Biomarker Operations Manager, Data Scientist.
  • Filed 4 certified LCAs in FY2026, the most recent disclosure year.

Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.

Salary Distribution

$71,323
$335,000
P25$113,750
Median$162,550
P75$188,750

The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.

100% of certified filings at or above the DOL prevailing wage.

Wage Level Distribution

Level I
0%
Level II
42%
Level III
42%
Level IV
17%

Levels I–IV are DOL prevailing-wage experience tiers; 58% of filings are senior-level (III–IV).

Filing history

LCA filings by fiscal year

Certified LCAs per year

FY2022
3
FY2023
1
FY2024
2
FY2025
2
FY2026
4
Fiscal yearCertifiedDeniedWithdrawnTotal
FY20223025
FY20231001
FY20242002
FY20252002
FY20264004

Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.

See a single year in detail:
FY2022 ›FY2023 ›FY2024 ›FY2025 ›FY2026 ›

All LCA filings

14 filings
Job titleSalaryLevelLocationFiledStatus
Senior CMC Project Manager
I-200-26168-025693
$140,000/yrIISpring, TXJun 17, 2026Certified
VP, Corporate Development
I-200-26168-025193
$335,000/yrIVBoulder, COJun 17, 2026Certified
Biomarker Operations Manager
I-200-26113-828830
$182,500/yrIIILebanon, OHApr 23, 2026Certified
Biomarker Operations Manager
I-200-26100-780123
$175,100/yrIIILebanon, OHApr 10, 2026Certified
Associate Vice President
I-200-25139-993488
$260,000/yrIIISan Francisco, CAMay 19, 2025Certified
Sr. Software Engineer
I-200-25113-896366
$185,000/yrIVJersey City, NJApr 23, 2025Certified
Sr. Manager, Business Development
I-200-23285-427212
$150,000/yrIIINew York, NYOct 12, 2023Certified
Cosmetics Project Manager
I-200-23279-415113
$90,000/yrIIBoulder, COOct 06, 2023Certified
Data Scientist
I-200-23236-292848
$120,000/yrIIIndianapolis, INAug 24, 2023Certified
Associate Vice President
I-200-22243-447869
$200,000/yrIIISan Francisco, CAAug 31, 2022Certified
Associate Vice President
I-200-22242-445588
$200,000/yrIIIBoulder, COAug 30, 2022Withdrawn
Data Engineer
I-200-22110-088825
$95,000/yrIIPittsburg, PAApr 20, 2022Certified
Platform Scientist
I-200-22101-056191
$71,323/yrIIBoulder, COApr 11, 2022Certified
Data Scientist
I-200-22096-042606
$71,323/yrIIBoulder, COApr 06, 2022Withdrawn

One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.

Every certified LCA needs its own Public Access File. Get the private gap check →
Sponsorship insights

How Enveda Therapeutics, Inc. sponsors H-1B talent

Petition Mix

New employment  43%Transfer (change of employer)  36%Continued employment  14%Amendments & other  7%
High transfer share (36%) — H-1B workers actively change employers to join Enveda Therapeutics, Inc..

Worker positions by LCA filing purpose, summed across FY2022–FY2026 disclosure records.

Filing Activity by Month

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Most active filing months: Apr and Aug — useful for timing transfer conversations.

Compliance Posture

Willful Violator
No
Full-Time Positions
100%
At/Above Prevailing Wage
100%

Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.

Roles & geography

Top sponsored roles & worksites

Top job titles

Associate Vice President
3 · $220,000
Biomarker Operations Manager
2 · $178,800
Data Scientist
2 · $95,662
Cosmetics Project Manager
1 · $90,000
Data Engineer
1 · $95,000

Top worksite locations

8 states · 8 cities

Boulder, CO
5
Lebanon, OH
2
San Francisco, CA
2
Indianapolis, IN
1
Jersey City, NJ
1
ElevateStaffing.ai Platform

Built for H-1B compliance teams

The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:

LCA & Public Access Files
Track every Labor Condition Application and auto-assemble the Public Access File within the DOL's 1-business-day window.
I-9 & E-Verify
Centralize I-9s and E-Verify status with automatic alerts before any work authorization lapses.
Visa & I-983 deadlines
Never miss an H-1B extension, EAD renewal, or STEM OPT I-983 evaluation — every deadline is tracked and alerted.
Audit & site-visit ready
FDNS site-visit and USCIS audit ready: every LCA posting, wage memo and document in one timestamped vault.
Explore more

Similar H-1B sponsors by filing volume

Sponsor H-1B talent? Know your gaps before an auditor does.

Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.

Get my private gap check →
Enveda Therapeutics, Inc. · audit readiness
0 need attention2 to watch2 clear
Get my private gap check →